Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there' - 2Vote in favor of your Number one kind of juice
- 3Figure out how to Team up with Your Auto Crash Legal advisor for Best Outcomes
- 4Russian drone slams into block of flats in deadly wave of strikes across Kyiv
- 5Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- ‘Downton Abbey: The Grand Finale’ hits streaming: How to watch, cast info and everything you need to know
- Guinea-Bissau's coup called a 'sham' by West African political figures
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Geminid meteor shower, one of the year's most reliable, peaks this weekend
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Well known Worldwide Caf\u00e9s to Experience
- Kiev declares energy emergency after Russian attacks amid winter cold
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- 'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
